Your browser doesn't support javascript.
loading
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC.
Gresele, Paolo; Falcinelli, Emanuela; Bury, Loredana; Alessi, Marie-Christine; Guglielmini, Giuseppe; Falaise, Céline; Podda, Gianmarco; Fiore, Mathieu; Mazziotta, Francesco; Sevivas, Teresa; Bermejo, Nuria; De Candia, Erica; Chitlur, Meera; Lambert, Michele P; Barcella, Luca; Glembotsky, Ana C; Lordkipanidzé, Marie.
Afiliação
  • Gresele P; Section of Internal and Cardiovascular Medicine, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Falcinelli E; Section of Internal and Cardiovascular Medicine, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Bury L; Section of Internal and Cardiovascular Medicine, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Alessi MC; Centre for CardioVascular and Nutrition Research, Institut National de la Sante et de la Recherche Medicale 1263, Institut National de la Recherche Agronomique 1260, Marseille, France.
  • Guglielmini G; Section of Internal and Cardiovascular Medicine, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Falaise C; Centre for CardioVascular and Nutrition Research, Institut National de la Sante et de la Recherche Medicale 1263, Institut National de la Recherche Agronomique 1260, Marseille, France.
  • Podda G; Dipartimento di Scienze della Salute, Medicina III, Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo, Università degli Studi di Milano, Milano, Italy.
  • Fiore M; Laboratory of Hematology, University Hospital of Bordeaux, Pessac, France.
  • Mazziotta F; Section of Internal and Cardiovascular Medicine, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Sevivas T; Serviço de Sangue e Medicina Transfusional, Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal.
  • Bermejo N; Hospital San Pedro de Alcantara, Caceres, Spain.
  • De Candia E; Hemostasis and Thrombosis Unit, Policlinico Universitario Agostino Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Chitlur M; Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Roma, Italy.
  • Lambert MP; Children's Hospital of Michigan, Detroit, Michigan, USA.
  • Barcella L; Children's Hospital of Philadelphia, Philadelphia, USA.
  • Glembotsky AC; Immunohematology and Transfusion Medicine & Hemostasis and Thrombosis Center, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
  • Lordkipanidzé M; Instituto de Investigaciones Médicas A. Lanari, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
Res Pract Thromb Haemost ; 8(1): 102305, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38292347
ABSTRACT

Background:

In hemophilia and von Willebrand disease, the degree of alteration of laboratory assays correlates with bleeding manifestations. Few studies have assessed the predictive value for bleeding of laboratory assays in patients with inherited platelet function disorders (IPFDs).

Objectives:

To assess whether there is an association between platelet function assay results and bleeding history, as evaluated by the International Society on Thrombosis and Haemostasis (ISTH) bleeding assessment tool (BAT).

Methods:

Centers participating in the international ISTH-BAT validation study were asked to provide results of the diagnostic assays employed for the patients they enrolled, and the association with the individual patients' bleeding score (BS) was assessed.

Results:

Sixty-eight patients with 14 different IPFDs were included. Maximal amplitude of platelet aggregation was significantly lower in patients with a pathologic BS and correlated inversely with the BS, a finding largely driven by the subgroup of patients with Glanzmann thrombasthenia and CalDAG-GEFI deficiency; after their exclusion, TRAP-induced aggregation remained significantly lower in patients with a pathologic BS. Bleeding time was significantly more prolonged in patients with a high BS than in those with a normal BS (27.1 ± 6.2 minutes vs 15.1 ± 10.6 minutes; P < .01). Reduced α-granule content was significantly more common among patients with a pathologic BS than among those with a normal BS (80% vs 20%; P < .05). Receiver operating characteristic curve analysis revealed a significant discriminative ability of all the aforementioned tests for pathologic BS (P < .001), also after exclusion of patients with Glanzmann thrombasthenia and CalDAG-GEFI deficiency.

Conclusion:

This study shows that altered platelet laboratory assay results are associated with an abnormal ISTH-BAT BS in IPFD.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália